Menu Search
Equities

MaxWin International Holdings Ltd

8513:HKG.HS

MaxWin International Holdings Ltd

Actions
  • Price (HKD)0.17
  • Today's Change0.006 / 3.66%
  • Shares traded1.16m
  • 1 Year change+226.92%
  • Beta--
Data delayed at least 15 minutes, as of May 23 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

MaxWin International Holdings Limited is a Singapore-based investment holding company. The Company is principally engaged in the manufacturing and sale of injection molded plastic parts for disposable medical devices and the provision of tooling services in Singapore. The Company’s segments include Components parts and Sum-assembly parts. The Component parts segment is engaged in manufacturing and trading of medical component parts. The Sub-assembly parts segment is engaged in manufacturing and trading of medical sub-assembly parts. The Company’s subsidiaries include Eastlyn Global Limited, Inzign Pte Ltd, Medizign Pte Ltd, and P.T. Inzign. P.T. Inzign is engaged in manufacturing of plastics articles and products.

  • Revenue in HKD (TTM)53.00m
  • Net income in HKD-26.55m
  • Incorporated2017
  • Employees92.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.